Gastroenterology
Volume 133, Issue 2 , Pages 702-705 , August 2007

In Search of Mechanisms of Change in Treatment Outcome Research: Mediators and Moderators of Psychological and Pharmacological Treatments for Irritable Bowel Syndrome

  • Jennifer S. Labus

      Affiliations

    • Corresponding Author InformationAddress requests for reprints to: Jennifer Labus, PhD, Center for Neurovisceral Sciences and Women’s Health, Neuroimaging Imaging Core, Peter V. Ueberroth Building, Room 2338C2, 10945 LeConte Avenue, Los Angeles, California 90095. fax: (310) 825-1919.

References 

  1. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132:397–414
  2. Mayer EA, Naliboff BD, Craig AD. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology. 2006;131:1925–1942
  3. Blanchard EB, Scharff L. Psychosocial aspects of assessment and treatment of irritable bowel syndrome in adults and recurrent abdominal pain in children. J Consult Clin Psychol. 2002;70:725–738
  4. Lackner JM, Mesmer C, Morley S, et al. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J Consult Clin Psychol. 2004;72:1100–1113
  5. Wilson S, Maddison T, Roberts L, et al. Birmingham IBS Research Group Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome. Aliment Pharmacol Ther. 2006;24:769–780
  6. Gholamrezaei A, Ardestani SK, Emami MH. Where does hypnotherapy stand in the management of irritable bowel syndrome? (A systematic review). J Altern Complement Med. 2006;12:517–527
  7. Whitehead WE. Hypnosis for irritable bowel syndrome: the empirical evidence of therapeutic effects. Int J Clin Exp Hypn. 2006;54:7–20
  8. Blanchard EB, Lackner JM, Sanders K, et al. A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome. Behav Res Ther. 2007;45:633–648
  9. Vlieger AM, Menko-Frankenhuis C, Wolfkamp SC, et al. Hypnotherapy for children with function abdominal pain or irritable bowel syndrome: a randomized controlled trial. Gastroenterology. 2007;[in Press]
  10. Tan G, Hammond DC, Joseph G. Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action. Am J Clin Hypn. 2005;47:161–178
  11. Guthrie E, Barlow J, Fernandes L, et al. North of England IBS Research Group Changes in tolerance to rectal distension correlate with changes in psychological state in patients with severe irritable bowel syndrome. Psychosom Med. 2004;66:578–582
  12. Cremonini F, Delgado-Aros S, Camilleri M. Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil. 2003;15:79–86
  13. Evans BW, Clark WK, Moore DJ, et al. Tegaserod for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2004;CD003960
  14. Jackson JL, O’Malley PG, Tomkins G, et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med. 2000;108:65–72
  15. Holroyd KA, O’Donnell FJ, Stensland M, et al. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA. 2001;285:2208–2215
  16. Holroyd KA, Penzien DB. Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials. Pain. 1990;42:1–13
  17. Holroyd KA, Drew JB. Behavioral approaches to the treatment of migraine. Semin Neurol. 2006;26:199–207
  18. Holroyd KA, Lipchik GL, Penzien DB. Psychological management of recurrent headache disorders: empirical basis for clinical practice. In:  Dobson KS,  Craig KD editor. Best Practice: Developing and Promoting Empirically Supported Interventions. Newbury Park, CA: Sage; 1998;p. 193–212
  19. Kraemer HC, Wilson GT, Fairburn CG, et al. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002;59:877–883
  20. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173–1182
  21. Laurenceau JP, Hayes AM, Feldman GC. Some methodological and statistical issues in the study of change processes in psychotherapy. Clin Psychol Rev. 2007;in press
  22. MacKinnon DP, Fairchild AJ, Fritz MS. Mediation analysis. Annu Rev Psychol. 2007;58:593–614
  23. Simren M. Hypnosis for irritable bowel syndrome: the quest for the mechanism of action. Int J Clin Exp Hypn. 2006;54:65–84
  24. Palsson OS, Turner MJ, Johnson DA, et al. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci. 2002;47:2605–2614
  25. Creed F, Guthrie E, Ratcliffe J, et al. North of England IBS Research Group Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder?. Aust N Z J Psychiatry. 2005;39:807–815
  26. Lackner JM, Jaccard J, Krasner SS, et al. How does cognitive behavior therapy for irritable bowel syndrome work? (A mediational analysis of a randomized clinical trial). Gastroenterology. 2007;133:433–444
  27. Walkup JT, Labellarte MJ, Riddle MA, et al. Research Units on Pediatric Psychopharmacology Anxiety Study Group Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2003;42:13–21
  28. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: The Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1088–1096
  29. Curry J, Rohde P, Simons A, et al. TADS Team Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;45:1427–1439
  30. Shrout PE, Bolger N. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods. 2002;7:422–445
  31. MacKinnon DP, Lockwood CM, Hoffman JM, et al. A comparison of methods to test mediation and other intervening variable effects. Psychol Meth. 2002;7:83–104
  32. Jaccard J, Guilamo-Ramos V, Johansson M, et al. Multiple regression analyses in clinical child and adolescent psychology. J Clin Child Adolesc Psychol. 2006;35:456–479
  33. Edwards JR, Lambert LS. Methods for integrating moderation and mediation: a general analytical framework using moderated path analysis. Psychol Meth. 2007;12:1–22
  34. Camilleri M, Mangel AW, Fehnel SE, et al. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol. 2007;5:534–540
  35. Committee DoTT, Irvine EJ, Whitehead WE, et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology. 2006;130:1538–1551

 Supported in part by K08 DK071626, R24 AT002681, P50 DK064539

PII: S0016-5085(07)01226-7

doi: 10.1053/j.gastro.2007.06.052

Gastroenterology
Volume 133, Issue 2 , Pages 702-705 , August 2007

Article Tools

* Image Usage & Resolution